Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromes

Am Heart J. 2000 Feb;139(2 Pt 2):S53-60. doi: 10.1067/mhj.2000.103741.
No abstract available

Publication types

  • Review

MeSH terms

  • Abciximab
  • Acute Disease
  • Antibodies, Monoclonal / therapeutic use
  • Coronary Disease / blood
  • Coronary Disease / drug therapy*
  • Drug Therapy, Combination
  • Electrocardiography / drug effects
  • Eptifibatide
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use
  • Peptides / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
  • Tirofiban
  • Treatment Outcome
  • Tyrosine / analogs & derivatives
  • Tyrosine / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Peptides
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Tyrosine
  • Tirofiban
  • Eptifibatide
  • Abciximab